Atlas Trials

Safety Study of Nifurtimox for Relapsed or Refractory Neuroblastoma

Clinical trial NCT00486564 · COMPLETED

Trial details

NCT number
NCT00486564
Sponsor
University of Vermont
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neuroblastoma
Start date
2006-11-01
Primary completion
2007-11-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.